Histological sample of skeletal muscle tissue under a microscope. Veru is testing a muscle-building drug in combination with Novo Nordisk's Wegovy to improve body composition in people with ...

ND0612 is an investigational drug-device therapy that provides a 24-hour continuous subcutaneous infusion of levodopa/carbidopa solution. The Food and Drug Administration (FDA) has accepted for ...

Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has designated the HADLIMA™ (adalimumab-bwwd) high- and low-concentration ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced that the Company received an RTF letter from the FDA for ...

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not posted for public view until weeks or months ...

NEW YORK -- The second week of testimony in the sex trafficking trial of Sean "Diddy" Combs ... "My friend, who's a doctor, a medical doctor, I asked him to come the next day to make sure she ...

violence and drug abuse. During Ventura’s trial testimony last week, she said she dated Mescudi in December 2011 after they had worked together briefly while she was “not in the greatest place ...

A cucumber recall has been linked to a salmonella outbreak in multiple states, including Illinois and Michigan, and is under investigation by the U.S. Food and Drug Administration, the agency ...

The Food and Drug Administration says it has decided to ... updates approved for seniors as well as people with an underlying medical condition, like pregnancy or diabetes, that increases the ...

The US Food and Drug Administration is changing the way it ... 6 months and older have at least one of these underlying medical conditions, according to the US Centers for Disease Control and ...

The Food and Drug Administration announced Tuesday it is ... the FDA will require “randomized, controlled trial data evaluating clinical outcomes” before a vaccine is approved.